human
respiratori
syncyti
viru
import
caus
sever
respiratori
diseas
young
children
elderli
immunocompromis
adult
similarli
bovin
respiratori
syncyti
viru
brsv
caus
sever
sometim
fatal
respiratori
diseas
calv
virus
pneumoviru
infect
human
respiratori
syncyti
viru
brsv
similar
clinic
patholog
epidemiolog
characterist
studi
use
ex
epitheli
cell
bronchi
apoptosi
longer
detect
thu
bronchi
indic
direct
contactdepend
tcellmedi
cytotox
primari
infect
j
human
respiratori
syncyti
viru
hrsv
common
caus
seriou
lower
respiratori
tract
infect
infant
young
children
elderli
peopl
immunocompromis
adult
also
high
risk
sever
hrsv
infect
develop
effect
prevent
therapeut
strategi
hamper
lack
knowledg
pathogenesi
hrsv
attempt
vaccin
children
formalininactiv
hrsv
vaccin
fail
enhanc
diseas
report
subsequ
hrsv
infect
vaccin
infant
vaccin
hrsv
current
avail
major
obstacl
develop
vaccin
immunolog
mechan
lead
either
protect
enhanc
diseas
clarifi
seem
part
ill
caus
natur
hrsv
infect
host
immun
respons
year
rsv
serum
antibodi
thought
play
role
enhanc
diseas
passiv
antibodi
prophylaxi
shown
antibodi
caus
acceler
viru
clearanc
without
harm
effect
although
improv
pulmonari
patholog
either
system
cellmedi
sensit
also
suggest
contribut
alter
respons
natur
hrsv
infect
occur
use
inactiv
hrsv
vaccin
context
mous
model
use
intens
studi
associ
tcell
subpopul
immunemedi
diseas
howev
work
focus
vaccineenhanc
diseas
wherea
lack
investig
pathogenesi
primari
infect
better
understand
pathogenesi
primari
infect
probabl
help
solv
conundrum
vaccineenhanc
diseas
hrsv
envelop
rna
viru
classifi
subfamili
pneumovirina
famili
paramyxovirida
bovin
respiratori
syncyti
viru
brsv
close
relat
viru
belong
subfamili
hrsv
hrsv
human
brsv
common
caus
lower
respiratori
tract
diseas
young
calv
clinic
epidemiolog
characterist
brsv
close
reflect
hrsv
establish
experiment
model
brsv
calv
studi
pathogenesi
rsv
infect
primari
advantag
model
studi
infect
natur
host
therefor
see
high
level
viral
replic
compar
experiment
model
instanc
mous
model
restrict
permiss
thu
calf
model
excel
model
studi
rsv
replic
clearanc
viru
present
studi
describ
replic
brsv
calv
differ
time
inocul
cell
replic
take
place
import
pathway
viral
clearanc
furthermor
influx
lymphocyt
neutrophil
macrophag
lung
examin
male
jersey
calv
week
age
deriv
two
close
herd
kept
isol
euthanasia
monitor
weekli
igm
igg
antibodi
brsv
describ
free
clinic
sign
respiratori
tract
diseas
time
inocul
none
calv
experienc
brsv
infect
inocul
calv
inocul
age
month
total
calv
includ
studi
inocul
brsv
mockinocul
inocul
divid
four
experi
experi
iv
ix
xi
xiv
experi
calv
inocul
day
inoculum
either
lung
wash
fluid
calf
infect
experiment
field
isol
brsv
use
experi
iv
cell
cultur
materi
brsvinfect
fetal
bovin
lung
cell
use
experi
ix
xi
xiv
describ
lung
wash
fluid
uninfect
calf
serv
mock
inoculum
experi
iv
wherea
uninfect
cell
cultur
fetal
bovin
lung
cell
use
mock
inoculum
remaind
calv
inocul
combin
intratrach
aerosol
rout
dose
experi
iv
experi
ix
tissu
cultur
infecti
dose
tcid
dilut
ml
phosphatebuff
salin
pb
administ
throughout
minut
mask
cover
nostril
mouth
waechtomat
inhal
vm
kruse
denmark
droplet
less
subsequ
dose
tcid
dilut
ml
pb
inject
trachea
calv
hous
togeth
time
inocul
control
calv
move
separ
similar
isol
unit
investig
influenc
agent
three
calv
experi
xi
treat
daili
mgkg
enrofloxacin
baytril
bayer
day
inocul
calv
kill
postinocul
day
pid
calv
anesthet
use
pentobarbit
euthan
exsanguin
pid
lung
trachea
immedi
remov
anim
photograph
taken
ventral
dorsal
side
lung
extent
consolid
lung
tissu
score
score
given
lung
complet
free
lesion
score
given
lung
spot
consolid
lung
tissu
lung
lung
lung
consolid
tissu
score
given
lung
tissu
cranial
medial
accessori
lobe
least
third
caudal
lobe
consist
consolid
tissu
tissu
sampl
eight
predetermin
site
right
lung
trachea
nasal
epithelium
ln
tracheobroncheali
tonsilla
palatina
spleen
fix
neutralbuff
formalin
furthermor
tonsilla
pharyngea
calv
also
fix
formalin
left
lung
lung
lavag
fluid
investig
infect
brsv
parainfluenza
viru
type
bovin
coronaviru
bovin
adenoviru
bovin
viral
diarrhea
viru
previous
describ
swab
tracheal
bronchu
use
mycoplasma
examin
sampl
lung
liver
spleen
bacteriolog
examin
describ
one
calf
kill
minut
necropsi
perform
describ
except
lung
lavag
left
lung
perform
instead
lung
sampl
six
differ
site
left
lung
well
eight
lung
sampl
right
lung
fix
formalin
furthermor
investig
infect
viru
mycoplasma
bacteria
perform
calf
demonstr
brsv
antigen
perform
formalinfix
tissu
describ
briefli
biotinyl
bovin
antibrsv
hyperimmuneserum
use
primari
antibodi
follow
incub
streptavidin
biotinyl
alkalin
phosphatas
dako
glostrup
denmark
fast
red
kementec
copenhagen
denmark
use
substrat
biotinyl
bovin
hyperimmuneserum
serv
neg
control
immunohistochemistri
detect
brsv
antigen
perform
section
fix
formalin
anim
immunohistochemistri
lung
section
perform
twice
gener
score
number
brsvposit
cell
whole
section
eight
standard
area
lung
evalu
three
section
differ
score
use
intern
control
includ
everi
batch
immunohistochemistri
number
posit
cell
section
estim
accord
three
section
section
cm
although
exactli
size
averag
eight
section
equal
differ
cell
demonstr
formalinfix
section
antibovin
monoclon
antibodi
clone
vmrd
pullman
wa
deparaffin
section
block
hydrogen
peroxid
trisbuff
salin
tb
moll
tri
ph
moll
nacl
rins
tb
pretreat
minut
proteas
sigma
tb
section
rins
tb
block
normal
swine
serum
tb
tbsnss
primari
antibodi
dilut
tbsnss
section
incub
overnight
incub
follow
minut
incub
rabbit
antimous
immunoglobulin
dako
dilut
tbsnss
minut
incub
peroxidaseantiperoxidas
complex
mous
monoclon
dako
dilut
tbsnss
section
wash
three
time
minut
tb
incub
final
section
incub
minut
dako
counterstain
second
harri
hematoxylin
cell
detect
describ
cell
two
antibovin
monoclon
antibodi
clone
vmrd
react
respect
mix
use
dilut
tbsnss
whole
section
three
eight
standard
area
lung
examin
obtain
score
number
cell
use
intern
control
describ
immunohistochem
demonstr
haemophilu
somnu
pasteurella
multocida
attempt
calv
bacteria
isol
method
describ
tegtmeier
colleagu
detect
brsv
antigen
follow
demonstr
either
epitheli
cell
macrophag
brsv
antigen
visual
incub
hour
biotinyl
bovin
antibrsv
hyperimmuneserum
follow
minut
incub
boehring
mannheim
mannheim
germani
section
incub
hour
xgal
substrat
histomark
kirkegaard
perri
laboratori
gaithersburg
demonstr
brsvposit
epitheli
cell
monoclon
antibodi
cytokeratin
dako
use
develop
brsv
signal
describ
section
store
overnight
tb
follow
minut
proteas
treatment
describ
incub
primari
antibodi
dilut
tbsnss
rabbit
antimous
dako
dilut
alkalin
phosphataseantialkalin
phosphatas
complex
dako
dilut
use
secondari
tertiari
antibodi
respect
incub
minut
section
incub
minut
fast
red
kementec
counterstain
second
harri
hematoxylin
monoclon
antibodi
dako
use
primari
antibodi
demonstr
brsvposit
macrophag
section
kept
overnight
tb
follow
minut
proteas
treatment
incub
overnight
dilut
tbsnss
reaction
demonstr
alkalin
phosphataseantialkalin
phosphatasefast
red
describ
cytokeratin
stain
doubleposit
cell
purpl
could
easili
differenti
singleposit
cell
either
clear
blue
xgal
red
fast
red
situ
hybrid
perform
formalinfix
section
previous
describ
probe
strandspecif
rna
probe
radiolabel
sutp
neg
sens
probe
use
demonstr
replic
clone
middl
part
n
f
gene
describ
previous
use
dna
templat
probe
probe
use
separ
combin
situ
cell
death
detect
kit
ap
boehring
mannheim
termin
dutp
nickend
label
reaction
use
demonstr
apoptot
cell
formalin
fix
tissu
section
deparaffin
section
treat
gml
proteinas
k
boehring
mannheim
mmoll
tri
ph
mmoll
cacl
minut
section
rins
twice
tb
protocol
manufactur
follow
except
tb
use
instead
pb
section
develop
fast
red
kementec
minut
room
temperatur
natur
occur
brsv
infect
individu
differ
sever
diseas
clinic
sign
diseas
rang
mild
cough
sever
respiratori
distress
cough
hyperpnea
tachypnea
anorexia
promin
clinic
featur
clinic
pictur
correspond
well
record
patholog
chang
spontan
cough
brsv
inocul
calv
start
pid
sever
clinic
sign
seen
pid
experiment
infect
xiv
two
calv
die
pid
despit
antibiot
antiinflammatori
treatment
calv
includ
gross
lesion
experiment
brsvinfect
calv
describ
natur
brsvinfect
calv
chang
progress
small
lobular
area
consolid
pid
total
consolid
cranial
middl
accessori
part
caudal
lobe
sever
affect
anim
kill
pid
interstiti
edema
mucupurul
exud
trachea
bronchi
seen
pid
wherea
emphysema
present
sever
affect
calv
kill
pid
three
five
calv
kill
pid
emphysema
especi
pronounc
caudal
lobe
also
seen
middl
accessori
lobe
consolid
area
persist
one
two
calv
kill
pid
one
three
calv
kill
pid
score
extent
macroscop
chang
lung
obtain
anim
given
tabl
schemat
outlin
brsvinfect
calv
given
figur
clinic
sign
observ
mockinocul
calv
two
mockinocul
calv
kill
pid
macroscop
chang
lung
wherea
one
small
lobular
consolid
area
observ
remaind
control
calv
tabl
brsvinfect
calv
show
less
sever
bronchopneumonia
depend
pid
shift
main
lesion
bronchiti
pid
bronchiol
alveol
pid
characterist
microscop
chang
correl
site
brsv
replic
neither
brsv
replic
antigen
could
demonstr
calf
kill
minut
tabl
wherea
replic
brsv
calv
kill
pid
demonstr
scatter
bronchial
epitheli
cell
situ
hybrid
neg
sens
probe
figur
immunohistochemistri
reveal
brsv
antigen
cell
parallel
section
figur
consequ
appli
epitheli
cell
demonstr
brsv
antigen
reflect
replic
neither
brsv
replic
antigen
detect
bronchiolar
alveolar
epitheli
cell
pid
tabl
replic
brsv
bronchial
epitheli
cell
pronounc
pid
whole
epitheli
line
mani
larg
bronchi
replic
viru
brsv
antigen
mainli
demonstr
lumin
part
brsv
replic
epitheli
cell
includ
cilia
larg
amount
antigen
could
demonstr
figur
bronchial
epitheli
cell
appear
mainli
intact
desquam
epithelium
occasion
seen
contrast
pid
replic
also
observ
bronchiolar
alveolar
epitheli
cell
replic
lobular
distribut
sever
aggrav
lesion
observ
lung
calv
kill
pid
compar
earlier
pid
especi
alveol
cellular
infiltr
alveoli
pronounc
edema
observ
alveoli
bronchiti
hyperplasia
bronchial
epithelium
still
present
mani
bronchial
epitheli
cell
lost
cilia
epithelium
seem
irregular
microscop
find
correl
extens
replic
brsv
bronchial
bronchiolar
alveolar
cell
pid
figur
calv
kill
pid
bronchial
epithelium
start
look
regular
although
cilia
still
absent
neither
brsv
replic
antigen
could
demonstr
bronchial
epitheli
cell
wherea
limit
number
bronchiolar
alveolar
epitheli
cell
still
replic
brsv
bronchiol
alveoli
also
bronchi
plug
cellular
exud
furthermor
edema
fibrin
pronounc
alveoli
pid
pid
peak
pid
larg
number
syncytia
seen
bronchiol
alveoli
bronchi
immunostain
use
antibodi
cytokeratin
reveal
syncytia
epitheli
origin
situ
hybrid
demonstr
support
replic
brsv
calv
kill
pid
overal
pictur
repair
neither
brsv
replic
antigen
could
demonstr
although
patholog
chang
still
present
bronchiol
obliteran
observ
lobul
often
caus
collaps
surround
alveoli
brsv
could
detect
calv
kill
pid
two
three
calv
patholog
chang
chang
third
calf
mild
character
hyperplasia
bronchialassoci
lymphoid
tissu
limit
number
neutrophil
bronchiol
alveoli
furthermor
bronchiol
obliteran
occasion
observ
schemat
outlin
replic
lung
brsvinfect
calv
given
figur
base
morpholog
difficult
determin
alveolar
cell
replic
brsv
replic
brsv
alveolar
type
epitheli
cell
easili
recogniz
figur
wherea
larg
mononuclear
brsvreplic
cell
protrud
alveolar
wall
situat
alveolar
lumen
could
alveolar
type
ii
epitheli
cell
well
alveolar
macrophag
doubl
immunohistochemistri
use
xgal
fast
red
substrat
made
possibl
clearli
distinguish
two
differ
singlestain
popul
doubleposit
cell
figur
doubl
immunohistochemistri
demonstr
alveolar
type
ii
epitheli
cell
contain
larg
amount
brsv
antigen
figur
cell
correspond
larg
cell
replic
brsv
seen
situ
hybrid
contrast
alveolar
macrophag
demonstr
use
antibodi
macrophag
contain
tabl
b
schemat
outlin
presenc
brsv
antigen
reflect
replic
bronchial
bronchiolar
alveolar
epitheli
cell
brsv
antigen
score
averag
score
anim
kill
pid
see
tabl
brsv
antigen
signal
brsv
antigen
weak
compar
signal
obtain
epitheli
cell
addit
epithelium
lung
nasal
tracheal
epithelium
also
replic
brsv
lumin
part
epitheli
cell
cours
replic
epitheli
cell
similar
seen
bronchial
epithelium
replic
brsv
demonstr
outsid
respiratori
tract
cell
bronchialassoci
lymphoid
tissu
region
lymph
node
replic
brsv
although
lymphoid
tissu
stimul
likewis
replic
demonstr
tonsilla
palatina
howev
epitheli
cell
cover
tonsilla
pharyngea
tonsilla
pharyngea
contrast
tonsilla
palatina
cover
respiratori
epithelium
strongli
support
replic
calv
kill
pid
figur
cours
replic
known
examin
tonsil
anim
lymphoid
tissu
epithelium
replic
brsv
result
demonstr
replic
brsv
start
upper
respiratori
tract
includ
nasal
tracheal
bronchial
epithelium
follow
replic
bronchiolar
alveolar
epithelium
day
later
replic
take
place
epitheli
cell
wherea
brsv
antigen
rare
found
alveolar
macrophag
b
h
c
e
f
g
analog
brsv
replic
clearanc
viru
first
occur
proxim
part
respiratori
tract
pid
epithelium
bronchi
look
irregular
sever
vacuol
contain
brsv
antigenposit
materi
observ
figur
vacuol
situat
cytoplasm
cell
flat
peripher
place
nucleu
contain
phagocyt
cellular
debri
figur
numer
apoptot
cell
characterist
fragment
nuclei
detect
bronchial
epithelium
termin
dutp
nickend
label
system
figur
apoptot
cell
desquam
bronchial
lumen
cell
situat
vacuol
demonstr
phagocyt
materi
describ
consist
apoptot
cell
difficult
character
phagocyt
cell
larg
vacuol
spars
cytoplasm
gener
matur
macrophag
rare
detect
bronchial
epithelium
infect
number
phagocyt
cell
morpholog
suggest
phagocyt
cell
neighbor
epitheli
cell
immunostain
anticytokeratin
demonstr
epitheli
origin
difficult
intens
stain
neighbor
epitheli
cell
later
pid
mani
alveolar
cell
demonstr
apoptot
sever
phagocyt
cell
ident
alveolar
phagocyt
cell
uncertain
apoptot
cell
found
lung
mockinocul
calv
result
demonstr
clearanc
viru
fast
apoptosi
seem
import
pathway
viral
clearanc
bronchial
epithelium
apoptot
bronchial
cell
detach
bronchial
lumen
cell
phagocyt
probabl
neighbor
epitheli
cell
lymphocyt
detect
lamina
propria
bronchi
anim
tabl
howev
number
cell
low
control
calv
number
cell
increas
infect
figur
even
though
individu
differ
begin
infect
lymphocyt
found
lamina
propria
submucosa
among
epitheli
cell
even
calv
kill
pid
vacuol
contain
phagocyt
apoptot
cell
seen
epithelium
lymphocyt
observ
among
epitheli
cell
figur
one
anim
kill
pid
cell
present
epithelium
time
apoptosi
longer
detect
bronchial
epithelium
higher
number
cell
seen
among
bronchial
epitheli
cell
one
calf
kill
pid
time
cell
detect
lumen
bronchi
well
figur
one
three
calv
kill
pid
high
number
cell
lung
anim
still
minor
patholog
chang
wherea
two
anim
low
number
cell
patholog
chang
thu
see
increas
number
cell
infect
time
apoptot
bronchial
epitheli
cell
demonstr
cell
situat
lamina
propria
direct
contact
epitheli
cell
howev
later
infect
especi
pid
cell
detect
bronchial
epitheli
cell
consolid
possibl
establish
local
cell
alveoli
although
brsv
antigen
found
alveolar
macrophag
cell
seem
import
cell
type
phagocytosi
viral
materi
earli
pid
neutrophil
seen
pass
bronchial
epithelium
toward
lumen
moder
number
neutrophil
detect
lumen
bronchi
higher
number
neutrophil
seen
pid
cell
observ
lumen
bronchi
contain
brsv
antigen
wherea
brsv
antigen
demonstr
neutrophil
migrat
bronchial
epitheli
cell
toward
lumen
later
pid
especi
pid
lumen
bronchi
bronchiol
alveoli
fill
inflammatori
exud
compos
predominantli
neutrophil
contain
abund
amount
viral
antigen
figur
replic
brsv
figur
demonstr
immunohistochemistri
situ
hybrid
respect
comparison
number
alveolar
macrophag
much
smaller
contain
brsv
antigen
therefor
neutrophil
probabl
major
phagocyt
cell
viru
antigen
particl
reach
bronchial
lumen
tabl
howev
togeth
mucu
desquam
epitheli
cell
neutrophil
also
respons
obliter
bronchi
later
pid
also
bronchiol
alveolar
lumina
later
pid
immunostain
use
demonstr
high
number
alveolar
macrophag
alveoli
especi
anim
figur
macrophag
seen
late
cours
infect
larg
activ
contain
phagocyt
neutrophil
figur
result
demonstr
import
neutrophil
clearanc
brsv
situat
lumen
airway
wherea
high
number
alveolar
macrophag
observ
later
infect
seem
import
clear
neutrophil
debri
apart
brsv
virus
detect
calv
wherea
mycoplasma
andor
ureaplasma
isol
calv
includ
mockinocul
calv
without
clinic
sign
patholog
chang
tabl
h
somnu
isol
calv
kill
pid
p
multocida
isol
calv
kill
pid
calv
kill
pid
furthermor
pasteurella
avium
isol
one
three
calv
kill
pid
bacteria
isol
brsvinfect
calv
correl
clinic
signsmacroscop
chang
bacteri
isol
moreov
calv
experi
xi
treat
antibiot
inocul
bacteria
could
isol
also
develop
sever
clinic
sign
patholog
chang
differ
microscop
chang
seen
calv
compar
calv
kill
pid
bacteria
could
demonstr
either
histochem
immunohistochem
method
brsvinfect
calv
bacteria
isol
wherea
bacteria
could
easili
detect
immunohistochemistri
includ
posit
control
section
data
shown
studi
demonstr
time
cours
viral
replic
clearanc
calv
experiment
infect
brsv
abl
show
replic
brsv
start
upper
part
respiratori
tract
includ
nasal
tracheal
bronchial
epithelium
replic
brsv
bronchial
epithelium
peak
around
pid
contrast
detect
replic
lower
respiratori
tract
pid
extens
replic
bronchiolar
alveolar
epithelium
seen
pid
detect
viru
lung
calf
kill
minut
inocul
precis
distribut
inoculum
known
pid
bronchial
epitheli
cell
posit
brsv
replic
antigen
wherea
high
number
posit
bronchial
epitheli
cell
pid
inoculum
theori
reach
alveoli
aerosol
inocul
droplet
less
possibl
eclips
phase
seen
upper
respiratori
tract
longer
lower
respiratori
tract
explain
delay
onset
replic
lower
respiratori
tract
howev
like
major
part
inoc
ulum
stuck
mucu
layer
upper
respiratori
tract
without
reach
alveoli
time
extens
viral
replic
bronchial
epithelium
infect
spread
downward
bronchiolar
alveolar
epithelium
mayb
result
cilia
destruct
bronchial
epithelium
replic
brsv
pronounc
lumin
part
epithelium
also
describ
hrsv
natur
brsvinfect
calv
larg
amount
brsv
antigen
demonstr
cilia
bronchial
epitheli
cell
pid
led
cilia
destruct
describ
electron
microscop
examin
sever
clinic
sign
tachypnea
anorexia
manifest
pid
coincid
maximum
replic
alveolar
epitheli
cell
calv
replic
restrict
upper
respiratori
tract
includ
bronchial
epitheli
cell
cough
demonstr
sever
clinic
sign
clinic
progress
ill
upper
respiratori
tract
infect
lower
respiratori
tract
infect
also
describ
young
children
hrsv
infect
immunocompromis
human
adult
demonstr
correl
progress
clinic
sign
viral
replic
may
explain
monthli
administr
rsv
antibodi
highrisk
children
seem
effect
reduc
number
sever
respiratori
diseas
young
children
presenc
high
level
antibodi
might
prevent
spread
viral
replic
lower
part
respiratori
tract
therebi
prevent
sever
diseas
although
number
matur
alveolar
macrophag
increas
experiment
brsv
infect
rare
contain
brsv
antigen
instead
found
larg
brsvreplic
cell
alveoli
alveolar
type
ii
epitheli
cell
thu
although
rule
small
subpopul
alveolar
macrophag
replic
brsv
describ
vitro
studi
epitheli
cell
far
import
viru
replic
furthermor
result
indic
alveolar
macrophag
play
minor
role
phagocyt
brsv
wherea
seem
import
phagocyt
neutrophil
process
repair
pid
high
number
neutrophil
seen
lumen
bronchi
earli
pid
brsv
antigen
demonstr
neutrophil
pid
later
pid
contain
high
amount
antigen
howev
sensespecif
situ
hybrid
reveal
cell
replic
viru
lumen
bronchi
bron
chiol
later
alveoli
often
plug
cellular
debri
consist
mostli
neutrophil
later
mix
desquam
epitheli
cell
macrophag
plug
cellular
debri
also
describ
autopsi
studi
infant
young
children
fatal
hrsv
infect
howev
case
main
chang
children
describ
mononuclear
infiltr
varianc
probabl
caus
differ
durat
infect
also
observ
increas
infiltr
cell
macrophag
infect
similar
studi
analysi
cell
obtain
bronchial
lavag
infant
hrsv
infect
demonstr
excess
number
neutrophil
upper
lower
airway
studi
show
neutrophil
import
clearanc
brsv
excret
lumen
respiratori
tract
wherea
neutrophil
migrat
bronchial
epithelium
contain
brsv
antigen
investig
need
determin
whether
neutrophil
might
contribut
observ
tissu
damag
releas
inflammatori
product
howev
block
airway
neutrophil
probabl
part
reason
advanc
respiratori
distress
emphysema
seen
especi
pid
might
caus
trap
air
clearanc
viru
brsvinfect
calv
elaps
order
replic
alreadi
pid
viru
clear
bronchial
epithelium
even
brsv
antigen
could
longer
detect
calv
kill
pid
pid
shown
replic
alveoli
stop
pid
leav
short
time
onset
clinic
sign
demonstr
brsv
viru
isol
antigen
demonstr
diagnost
import
furthermor
find
may
explain
case
hrsv
could
detect
postmortem
immunohistochemistri
although
viru
demonstr
antemortem
studi
abl
demonstr
apoptosi
import
way
brsv
clearanc
larg
number
apoptot
cell
detect
bronchial
epithelium
pid
apoptot
brsv
antigencontain
cell
seen
vacuol
phagocyt
cell
regard
whole
apoptot
process
develop
morpholog
chang
degrad
phagocyt
apoptot
materi
describ
complet
hour
process
seem
major
way
viral
clearanc
bronchial
epithelium
phagocyt
cell
epithelium
mononuclear
larg
vacuol
spars
cytoplasm
cell
difficult
identifi
cell
type
howev
probabl
macrophag
number
matur
macrophag
epithelium
low
compar
high
number
phagocyt
cell
instead
like
phagocyt
cell
neighbor
epitheli
cell
phagocytosi
apoptot
cell
neighbor
cell
also
suggest
physiolog
apoptosi
hormonedepend
tissu
normal
colon
mucosa
cell
describ
import
viral
clearanc
lung
rsvinfect
mice
brsvinfect
gnotobiot
calv
present
studi
demonstr
increas
number
cell
lung
infect
pid
cell
demonstr
epithelium
bronchi
pid
apoptosi
detect
bronchial
epithelium
cell
could
demonstr
among
bronchial
epitheli
cell
eight
brsvinfect
calv
wherea
moder
number
cell
detect
lamina
propria
bronchi
calv
later
cours
infect
pid
cell
seen
bronchial
epithelium
lumen
bronchi
one
calf
suggest
imped
passag
bronchial
epithelium
lumen
bronchi
pid
consist
studi
brsvinfect
gnotobiot
calv
increas
number
cell
observ
flow
cytometri
bovin
lung
tissu
pid
bronchoalveolar
lavag
day
infect
cell
saw
increas
number
cell
infect
likewis
cell
detect
among
bronchial
epitheli
cell
pid
kill
cytotox
cell
gener
describ
occur
either
granzymeperforin
mediat
lysi
target
cell
fa
ligand
fasl
fa
interact
pathway
requir
direct
celltocel
contact
howev
studi
indic
effici
clearanc
brsv
bronchial
epithelium
mediat
anoth
mechan
contactdepend
tcellmedi
cytotox
vitro
studi
use
lung
epitheli
cell
line
demonstr
fa
fasl
upregul
infect
rsv
howev
absent
inhibit
apoptosi
block
fasfasl
pathway
suggest
limit
role
fasfasl
pathway
rsvinduc
apoptosi
cell
strong
activ
author
instead
suggest
direct
rsvinduc
apoptosi
occur
endoplasm
reticulum
stress
respons
increas
amount
data
suggest
direct
contactdepend
cytolysi
virusinfect
cell
cytotox
lymphocyt
way
viral
clearanc
seem
cytopath
virus
mainli
control
solubl
mediat
antibodi
cytokin
produc
immedi
vicin
infect
cell
interestingli
previous
detect
high
level
tumor
necrosi
lung
lavag
experiment
brsvinfect
calv
kill
pid
contrast
level
low
detect
calv
kill
pid
mockinocul
calv
therefor
possibl
local
product
import
rsv
clearanc
induc
apoptosi
mayb
combin
noncytopath
mechan
describ
hepat
b
viru
vivo
studi
mice
shown
antivir
cytokin
especi
releas
virusspecif
cytotox
lymphocyt
abl
purg
viru
infect
cell
noncytopath
manner
studi
necessari
reveal
produc
cell
situat
lamina
propria
interestingli
recent
studi
aung
colleagu
demonstr
perforin
knockout
mice
abl
clear
rsv
day
rsvinfect
wildtyp
mice
although
perforin
knockout
mice
higher
level
viru
pid
furthermor
perforin
knockout
mice
show
enhanc
diseas
togeth
increas
prolong
product
observ
consist
result
demonstr
direct
contactdepend
mechan
might
main
mechan
rsv
clearanc
howev
observ
tcell
contactindepend
mechan
viral
clearanc
appli
bronchial
infect
demonstr
widespread
apoptosi
alveoli
pid
apoptot
alveolar
cell
also
phagocyt
possibl
identifi
phagocyt
cell
imposs
decid
whether
direct
cell
contact
cell
sever
anim
model
rsv
develop
drawback
problem
calf
model
coinfect
mycoplasma
ureaplasma
anim
also
bacteria
howev
mycoplasma
also
detect
mockinocul
calv
without
clinic
sign
patholog
chang
furthermor
brsvinfect
calv
bacteria
mycoplasma
isol
similar
clinic
sign
patholog
chang
seen
brsvinfect
calv
without
coinfect
therefor
conclud
coinfect
signific
influenc
replic
clearanc
brsv
studi
experiment
model
fact
sever
clinic
sign
patholog
chang
continu
clearanc
viru
support
assumpt
exagger
immun
respons
import
pathogenesi
howev
result
demonstr
sever
patholog
chang
appear
replic
rsv
spread
alveoli
moreov
fact
rsv
infect
immunocompromis
infant
adult
caus
sever
even
fatal
lower
respiratori
tract
diseas
show
amount
viru
replic
also
import
pathogenesi
individu
prolong
rsv
excret
indic
vigor
host
immun
respons
insuffici
restrict
viral
replic
contribut
develop
sever
diseas
high
level
replic
calf
model
make
good
model
studi
replic
clearanc
rsv
conclud
apoptosi
import
way
clear
brsvinfect
bronchial
epitheli
cell
probabl
follow
phagocytosi
neighbor
epitheli
cell
wherea
neutrophil
import
clearanc
viru
situat
lumen
respiratori
tract
increas
infiltr
cell
seen
infect
could
demonstr
bronchial
epitheli
cell
pid
viral
replic
longer
could
demonstr
bronchial
epitheli
cell
suggest
direct
contactdepend
tcellmedi
cytotox
involv
clearanc
viru
primari
infect
howev
observ
relat
bronchi
pid
high
number
apoptot
cell
alveoli
well
anatom
structur
sever
alveol
possibl
determin
whether
cell
close
contact
apoptot
cell
investig
requir
studi
issu
